In a significant move to bolster public health research, the Centers for Disease Control and Prevention – ERA has announced a new funding opportunity, numbered RFA-GH-24-033, titled “Advancing Public Health Research in Bangladesh”. This grant, under the category of Cooperative Agreement, promises to inject a substantial sum of up to $22 million into the health sector of Bangladesh. The primary objective of this initiative is to enhance the capacity of the Government of Bangladesh and its global partners in effectively detecting, preventing, and responding to various disease threats through advanced public health research and surveillance activities.
Unique to this funding opportunity is its eligibility criteria, which designates icddr,b (formerly known as the International Centre for Diarrhoeal Disease Research, Bangladesh) as the sole applicant. The announcement, made on December 14, 2023, outlines the specific goals of the program, including determining the burden, trends, etiology, and risk factors of priority diseases in Bangladesh. Additionally, the grant aims to develop and evaluate new interventions and diagnostics, assess the effectiveness of vaccinations to shape global policy, and strengthen the nation’s surveillance, laboratory, and outbreak response capabilities. This comprehensive approach is expected to have a far-reaching impact on the public health landscape of Bangladesh and beyond.
Opportunity ID: 351514
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-GH-24-033 |
| Funding Opportunity Title: | Advancing Public Health Research in Bangladesh |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | |
| Expected Number of Awards: | 1 |
| CFDA Number(s): | 93.326 — Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 14, 2023 |
| Last Updated Date: | Dec 14, 2023 |
| Original Closing Date for Applications: | Mar 08, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Current Closing Date for Applications: | Mar 08, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Archive Date: | Apr 07, 2024 |
| Estimated Total Program Funding: | $ 22,000,000 |
| Award Ceiling: | $6,000,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | icddr,b (formally International Centre for Diarrhoeal Disease Research, Bangladesh) is the sole eligible applicant. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The purpose of this notice of funding opportunity is to further strengthen the ability of the Government of Bangladesh and other global partners to detect, prevent, and respond to disease threats through high quality public health research and surveillance activities. Specifically, the individual activities under this cooperative agreement will: a) determine burden, trends, etiology, and risk factors of priority diseases in Bangladesh, b) develop and evaluate interventions and diagnostics, c) evaluate the effectiveness of vaccinations to inform global policy, and d) strengthen the Government of Bangladesh’s surveillance, laboratory and outbreak response capacity. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact: Lata Kumar
lek7@cdc.gov |